RESEARCH TRIANGLE PARK, N.C., April 07, 2026 (GLOBE NEWSWIRE) — Merakris Therapeutics today provided an update on recent communications with the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug (IND) application for MTX-001, an investigational biologic being developed for venous leg ulcers (VLUs).
Peripheral/Endo
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Endospan’s NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease,…
Embolization, Inc., Polymer-Based Coil Demonstrates Success in Limited-Market Release
— Coils minimize artifacts in imaging with high packing density — BOULDER, Colo., April 2, 2026 /PRNewswire/ — The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., is demonstrating consistent success in its limited-market release, with use cases topping 70 coils….
Ellipsys Vascular Access System to Return to U.S. Market in 2026
Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 SAN CLEMENTE, Calif., April 2, 2026 /PRNewswire/ — Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial…
Shape Memory Medical Begins Enrollment in FLAGSHIP Study Evaluating Novel False Lumen Embolization Technology
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection. Aortic dissection is a life‑threatening condition in which a tear in the aortic wall creates a secondary channel known as
AIROS Medical Appoints Dr. John Evans as Lead Medical Advisor
AUDUBON, Pa., March 31, 2026 /PRNewswire/ — AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced the appointment of Dr. John N. Evans, DPM, FACFAS, DABFAS, to a lead role as Medical…
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
TAMPA, Fla., March 31, 2026 /PRNewswire/ — Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of a Sirolimus-coated balloon for Peripheral…
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
Endovascular Engineering Announces Dual Late-Breaking Presentations at SIR and SCAI 2026 Highlighting Validation of Blood Return and Comprehensive ENGULF Study Results
MENLO PARK, Calif., March 19, 2026 /PRNewswire/ — Endovascular Engineering, Inc. (“E2”) today announced that two abstracts related to the ENGULF study and the Hēlo® Platform have been accepted as late-breaking podium presentations at the Society of Interventional Radiology (SIR) Annual…
VentureMed Group Announces It Is Now Doing Business as Flex Vascular
MINNEAPOLIS, March 5, 2026 /PRNewswire/ — VentureMed Group, Inc., an innovative medical device company specializing in vessel preparation and access management for AV fistulas and grafts and peripheral vascular disease, today announced it is now doing business as Flex Vascular. The DBA…



